Get my own profile
Public access
View all6 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Wojciech KrzyzanskiAssociate Professor of Pharmaceutical Sciences, University at BuffaloVerified email at buffalo.edu
- Sameer DoshiAmgen Inc.Verified email at amgen.com
- Gustau Camps-VallsProfessor. Image Processing Lab (IPL). Universitat de ValčnciaVerified email at uv.es
- emilio soria-olivasVerified email at uv.es
- Per Olsson GisleskogManaging Director and Principal Consultant, POG PharmacometricsVerified email at pog-p.com
- Honghui ZhouHead of Pharmacometrics (US), Janssen Research & Development, Johnson & JohnsonVerified email at its.jnj.com
- Xiaoyu YanThe Chinese University of Hong KongVerified email at cuhk.edu.hk
- José D. Martin-GuerreroETSE-UV, Universitat de ValčnciaVerified email at uv.es
- italo poggesiJanssen R&DVerified email at its.jnj.com
- Joel S OwenExecutive Director - MIDD Lead, GSKVerified email at gsk.com
- John HarroldSenior Scientist, Amgen IncVerified email at amgen.com
- Daniel Von HoffChief Scientific Officer US Oncology, Chief Scientific Officer TGen, Distinguished Professor MayoVerified email at tgen.org
- Steven XuJanssen R&DVerified email at its.jnj.com
- Antonio J. Serrano LópezProfesor Universidad de ValenciaVerified email at uv.es
- David CunninghamThe Royal Marsden NHS Foundation TrustVerified email at rmh.nhs.uk
- Nick HolfordProfessor Emeritus Clinical Pharmacology, University of AucklandVerified email at auckland.ac.nz
- Elodie PlanPharmetheus, Uppsala UniversityVerified email at pharmetheus.com
- Mahesh N. SamtaniSenior Director, Janssen R&DVerified email at its.jnj.com
- Gilbert KochVerified email at uni-konstanz.de
- Jose Luis GorrizUniversity of ValenciaVerified email at uv.es
Follow
Juan Jose Perez Ruixo
Other namesJJ Perez-Ruixo, JJP Ruixo
Janssen Research & Development
Verified email at its.jnj.com